COVID-19 Vaccines for Children Under 5: UCSF Explains What You Should Know

Parents of children under the age of five-years-old now have the option to vaccinate their infants and young children against COVID-19. Our expert looks at potential vaccine side effects, risks of COVID-19, access and vaccine effectiveness in children.

In Long COVID, Blood Markers Are Linked to Neuropsychiatric Ills

In a new study of long COVID, UCSF researchers identified biomarkers present at elevated levels that may persist for many months in the blood of study participants who had long COVID with neuropsychiatric symptoms.

UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Scientists at UCSF QBI and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.

Navigating From the Genome to the Clinic Using ‘Cell Maps’

Nevan Krogan, PhD, director of UCSF’s Quantitative Biosciences Institute, examines in detail the effects of a handful of genes that seem to play an outsize role in a wide array of diseases.

COVID Drug May Also Ease Symptoms of Long COVID

An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.

Your Mental Health May Impact Your Chances of Breakthrough COVID

A new UCSF-led study showed that people who are vaccinated against COVID-19, and have a history of certain psychiatric conditions, have a heightened risk of infection – a finding that may be related to impaired immune response.

USCF Deploys Innovative Data System to Integrate Research and Care

UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.

UCSF Deploys Innovative Data System to Integrate Research and Care

UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.

Homeless Deaths Doubled in San Francisco During the Pandemic’s First Year, Mostly from Drug Overdoses

More than twice as many people experiencing homelessness in San Francisco died during the first year of the COVID-19 pandemic compared to previous years, with the leading cause of death being drug overdose. No deaths were attributed to the virus itself.

Cerebrospinal Fluid Offers Clues to Post-COVID ‘Brain Fog’

Many patients with COVID-19 develop brain fog and other cognitive symptoms months later. Their cerebrospinal fluid may hold clues to why this is happening.